IBT — International Biotechnology Trust Share News
0.000.00%
FinancialsBalancedSmall Cap
- £318.28m
- £345.06m
- £6.07m
REG - Intnl. Biotechnology - Net Asset Value(s)
AnnouncementREG - Intnl. Biotechnology - Net Asset Value(s)
AnnouncementREG - Intnl. Biotechnology - Net Asset Value(s)
AnnouncementREG - Intnl. Biotechnology - Net Asset Value(s)
AnnouncementREG - Intnl. Biotechnology - Net Asset Value(s)
AnnouncementREG - Intnl. Biotechnology - Net Asset Value(s)
AnnouncementREG - Intnl. Biotechnology - Net Asset Value(s)
AnnouncementREG - Intnl. Biotechnology - Net Asset Value(s)
AnnouncementREG - Intnl. Biotechnology - Net Asset Value(s)
AnnouncementREG - Intnl. Biotechnology - Net Asset Value(s)
AnnouncementREG - Intnl. Biotechnology - Net Asset Value(s)
AnnouncementREG - Intnl. Biotechnology - Compliance with Market Abuse Regulation
AnnouncementREG - Intnl. Biotechnology - Net Asset Value(s)
AnnouncementREG - Intnl. Biotechnology - Net Asset Value(s)
AnnouncementREG - Intnl. Biotechnology - Net Asset Value(s)
AnnouncementREG - Intnl. Biotechnology - Transaction in Own Shares
AnnouncementREG - Intnl. Biotechnology - Net Asset Value(s)
AnnouncementRCS - Intnl. Biotechnology - Portfolio company Soleno acquired by Neurocrine
AnnouncementREG - Intnl. Biotechnology - Transaction in Own Shares
Announcement